Physician profile
Eric Kreutzer
NPI 1407831324
$12,629.18
in general payments reported to CMS, 2019-2025
45 companies · $1,657 in 2025
The $1,657 reported for 2025 was more than what 75% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,613 · 2020: $982 · 2021: $1,428 · 2022: $1,873 · 2023: $2,331 · 2024: $1,744 · 2025: $1,657.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,732.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,732.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,908.28 | 2019-2025 | Erleada, Akeega |
| Sumitomo Pharma America, INC. | $1,784.95 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $1,310.86 | 2019-2025 | Xtandi, Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $863.69 | 2019-2025 | |
| Dendreon Pharmaceuticals LLC | $742.91 | 2019-2025 | Provenge |
| Endo Pharmaceuticals INC. | $687.80 | 2019-2024 | Xiaflex, Aveed, Edex |
| Pfizer INC. | $648.59 | 2019-2025 | |
| Abbvie INC. | $555.44 | 2019-2025 | |
| Myovant Sciences INC. | $383.42 | 2021-2022 | |
| Allergan, INC. | $378.64 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $366.33 | 2020-2025 | Lynparza, Keytruda |
| Tolmar Pharmaceuticals, INC. | $335.66 | 2019-2022 | |
| Urovant Sciences INC | $283.31 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $272.84 | 2019-2025 | Adstiladrin |
| Janssen Scientific Affairs, LLC | $198.90 | 2019-2020 |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $181.12 | 2023-2025 | Pylarify |
| Aytu Biopharma, INC. | $137.84 | 2019-2020 | |
| Amgen INC. | $135.32 | 2019-2021 | |
| Accord Healthcare, INC. | $125.49 | 2022-2024 | |
| Axonics, INC. | $114.36 | 2021-2023 | Bulkamid, Axonics |
| Neotract INC. | $104.39 | 2019 | |
| Boston Scientific Corporation | $102.33 | 2020-2024 | Rezum Generator |
| Blue Earth Diagnostics | $100.75 | 2019-2022 | |
| Photocure INC | $91.44 | 2019-2025 | Cysview |
| Clarus Therapeutics INC. | $82.23 | 2021 | |
| Endo USA, INC. | $81.30 | 2025 | Xiaflex, Aveed |
| Alnylam Pharmaceuticals INC. | $79.39 | 2023 | Givlaari |
| Tolmar, INC. | $69.39 | 2023-2024 | |
| Sun Pharmaceutical Industries INC. | $64.82 | 2022-2024 | Yonsa |
| Dentsply Ih INC. | $62.05 | 2019-2021 | |
| Immunitybio, INC. | $56.28 | 2025 | |
| Coloplast Corp | $42.77 | 2019-2025 | |
| Teleflex LLC | $35.84 | 2023-2025 | Urolift, Barrigel |
| Verity Pharmaceuticals INC. | $32.75 | 2023 | Trelstar |
| Srs Medical Systems, INC. | $28.65 | 2024-2025 | Urocuff-Dc Disposable, Single, Ct3000 Pro Base Unit |
| Acerus Pharmaceuticals Corporation | $26.50 | 2022 | |
| Hollister Incorporated | $25.32 | 2023 | Onli, Vapro Pocket |
| Lantheus Medical Imaging, INC. | $24.43 | 2024 | |
| Urogen Pharma, INC. | $20.80 | 2023 | Jelmyto |
| 180 Medical, INC. | $19.81 | 2019 | |
| Laborie Medical Technologies Corp. | $14.23 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Olympus America INC. | $12.46 | 2022 | |
| Rochester Medical Corporation | $12.29 | 2019 | |
| Metuchen Pharmaceuticals | $11.61 | 2020 | |
| Janssen Pharmaceuticals, INC | $11.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Kreutzer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.